Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The proposed invention will provide a competitive advantage to any company or organization involved with the regulation of gene expression, cancer research, rational drug design, or any research and development More
Genetic Test Predictive of Severity of Cystic Fibrosis Pulmonary Disease More
Epigenetic Biomarkers for the Minimally Invasive Diagnosis of Foetal Genetic Disease More
Genetic Association of Familial Combined Hyperlipidaemia for Diagnostic and Pharmacogenomic uses More
Polymorphism and Genetic Susceptibility to Thyroid Dysgenesis: For Diagnosis an Increased Likelihood of Developing a TD More
The Role of the Cholesterol Transport Gene in the Intestinal Transport of Cholesterol: Screening for Novel Cholesterol-Lowering Drugs More
Development of a Novel Ditag Genome Scanning Technology More
Method of Screening for Fragile X Syndrome: Development of an Accurate Diagnostic Marker More
Assay for Detection of Glycan Modification of Muscle Cells and Resulting Discovery of Potential Muscular Dystrophy Therapeutic More
New Science Solutions for Clinical Development More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2011 - 209 pages - $3,500
Jul 2011 - 136 pages - $500
Apr 2011 - 26 pages - $500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Nov 2010 - 330 pages - $1,495
Nov 2010 - 527 pages - $1,495
May 2011 - 34 pages - $500
Apr 2011 - 56 pages - $3,800
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Birth defects
- Blood clotting disorders
- Fabry's disease
- Gaucher's disease
- Genetic disorder (other)
- Hunter's syndrome
- Huntington's disease
- Kawasaki disease
- Klinefelter's syndrome
- Phenylketonuria
- Severe combined immunodeficiency
- Turner's syndrome
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us